Delivery Order SPE2DB22D9207-SPE2DB24FH4VE
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of 3.5 mg vials of the pharmaceutical product VELCADE with a potential value of $2,331.44. The delivery order has a completion date of February 12, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that provides a wide range of brand and generic prescription and over-the-counter drug...
- This firm-fixed-price delivery order contract, awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, provides for the delivery of VELCADE 3.5 MG VIALS to support the pharmaceutical supply needs of military health facilities. The contract has a ceiling value of $23,314.40 and a period of performance through April 2024. DMS Pharmaceutical Group holds an indefinite delivery vehicle (IDV) contract with DLA, valued at up to $4,999,999 through...
- The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 3.5 mg vials of the pharmaceutical drug VELCADE. The $13,988.64 contract has a completion date of March 7, 2024 and is not set aside for any special designation. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds a larger indefinite delivery contract with DLA, valued up to $4,999,999 through 2025, to deliver a...
- This is a $23,314.40 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of VELCADE 3.5 MG VIALS and has a completion date of June 4, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program to provide a comprehensive range of pharmaceutical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $17,151.45 contract is for the delivery of VELCADE 3.5 MG VIALS, a specialized oncology medication, with a period of performance through December 22, 2023. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $13,988.64 firm fixed-price contract is for the delivery of VELCADE 3.5 MG VIALS to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,657.20 contract is for the delivery of VELCADE 3.5 MG VIALS to support the recurring medical supply needs of military health facilities. This order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $13,758.60 delivery order is for the supply of VELCADE 3.5 MG VIALS, a specialty oncology medication. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue delivery orders for a...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of Velcade 3.5 mg vials. The contract has a potential value of $23,314.40 and a completion date of March 14, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that provides a wide range of brand and generic prescription and over-the-counter drug...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, on March 27, 2024. The contract, valued at $11,657.20, is for the delivery of 3.5 mg vials of the cancer medication VELCADE. The order has an ultimate completion date of April 17, 2024. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract, SPE2DB, that DMS Pharmaceutical Group holds with the DLA, valued at up to...
- SPE2DB22D9207Indefinite Delivery Contract
- SPE2DB22D9207-SPE2DB24FH4VEDelivery Order
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of VELCADE 3.5 mg vials, with a potential value of $10,290.87. The contract has a completion date of January 11, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that provides a wide range of pharmaceutical and medical products to the federal government, primarily the Department of Defense. The company holds various federal contracts and indefinite delivery vehicles to supply pharmaceuticals and medical products in support of military treatment facilities worldwide. This delivery order is likely part of a larger contract vehicle that DMS Pharmaceutical Group Inc. holds with DLA to provide pharmaceutical items and medical supplies to military treatment centers globally on a firm fixed price basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.3k | 12/19/23 |